Litigation Details for Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2014-07-16
Court	District Court, D. Delaware	Date Terminated	2017-04-25
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	MYLAN PHARMACEUTICALS INC.
Patents	8,007,826; 8,354,437; 8,440,703; 8,663,685
Attorneys	Jack B. Blumenfeld; Mary Matterer
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2014-09-08	15		8,007,826; 8,354,437; 8,440,703; and 8,663,685. 3 Due to the 45-day statutory deadline, such protective… the Orange Book-listed patents which protect the product (the “Ampyra Patents”).2 (Complaint ¶¶ 34-35…There are five Orange Book-listed patents for Ampyra: United States Patent Nos. 5,540,938; 8,007,… Notwithstanding that Mylan regularly litigates patent infringement cases in this district and that the… that Plaintiffs have sued for infringing the patents-in-suit all have agreed to jurisdiction in this	External link to document
2015-01-14	30		five patents-in-suit: U.S. Patent Nos. 5,540,938 (the '"938 patent"), 8,007,826 (the …the "'826 patent"), 8,354,437 (the "'437 patent"), 8,440,703 (the '"…"703 patent"), and 8,663,685 (the "'685 patent") (collectively, "the Arnpyra…Arnpyra® patents"). All of the Arnpyra® patents are listed in the FDA's "Orange Book"…information about their patents .... [T]he FDA ... [then] publishes the ... patent numbers and expiration	External link to document
2014-07-16	4		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437…2014 25 April 2017 1:14-cv-00935 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document